These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Natural history of multiple sclerosis: a unifying concept. Confavreux C; Vukusic S Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308 [TBL] [Abstract][Full Text] [Related]
9. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses]. Svenningsson A; Andersson M; Olsson T Lakartidningen; 1998 Dec; 95(49):5623-7, 5630. PubMed ID: 9863300 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis. Charles J; Valenti L; Britt H Aust Fam Physician; 2011 Dec; 40(12):947. PubMed ID: 22256380 [TBL] [Abstract][Full Text] [Related]
12. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
13. Concepts of induction and escalation therapy in multiple sclerosis. Rieckmann P J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple sclerosis]. Simó M Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815 [TBL] [Abstract][Full Text] [Related]
15. The management of pediatric multiple sclerosis. Yeh EA; Weinstock-Guttman B J Child Neurol; 2012 Nov; 27(11):1384-93. PubMed ID: 22914373 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Cadavid D; Wolansky LJ; Skurnick J; Lincoln J; Cheriyan J; Szczepanowski K; Kamin SS; Pachner AR; Halper J; Cook SD Neurology; 2009 Jun; 72(23):1976-83. PubMed ID: 19279320 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of multiple sclerosis. Calabresi PA Am Fam Physician; 2004 Nov; 70(10):1935-44. PubMed ID: 15571060 [TBL] [Abstract][Full Text] [Related]
18. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis. Schwid SR; Panitch HS Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and disease modifying treatments in multiple sclerosis. Zajicek J Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683 [TBL] [Abstract][Full Text] [Related]
20. Benign multiple sclerosis in Crete. Mastorodemos V; Nikolakaki H; Tzagournissakis M; Kotzamani D; Panou T; Spanaki C; Klados G; Maris T; Kontolaimaki E; Psaroudaki K; Chlouverakis G; Georgakakis G; Plaitakis A Mult Scler; 2010 Jun; 16(6):701-6. PubMed ID: 20237192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]